Valida Health ApS: Financial statements 2022
CVR: 41344806
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Valida Health ApS (CVR 41344806) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,673,712 and a net result of DKK -820,169 compared with DKK 9,360,476 the year before. That is a decrease of 84.8% compared with the year before. Equity in the 2022 report amounted to DKK 2,280,819. The solvency ratio was 45.2%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 2,673,712
- Profit/Loss
- DKK -820,169
- Equity
- DKK 2,280,819
- Total Assets
- DKK 5,050,161
- Employees
- 5
Official annual report
Keep an eye on Valida Health ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 30, 2022, Titus Sixten Hinsch Gylvin has left the board of directors of Valida Health ApS.
Valida Health ApS has published its annual report for 2021. Gross profit came to DKK 17,575,696, and the net result was DKK 9,360,476.
As of March 30, 2022, Titus Sixten Hinsch Gylvin has stepped down as director of Valida Health ApS.
About Valida Health ApS
Valida Health ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Ulf Bech Christensen. The board consists of Ulf Bech Christensen (chair). The company is owned by Scient. Family Invest ApS. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 1,514,356 and a net result of DKK -2,235,431 compared with DKK -3,887,708 the year before. Equity in the 2025 report amounted to DKK -1,221,452.